Alyeska Investment Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,353	Closed	-$86K	–	489
2018 Q3	$86K	Sell	4,353 -95,647	-96%	-$1.89M	﹤0.01%	360
2018 Q2	$3.18M	Buy	+100,000	New	+$3.18M	0.03%	294